Influence of toyocamycin on the assembly and processing of preribosomal ribonucleoproteins in the nucleolus of mammalian cells.
The adenosine analogue toyocamycin inhibits the maturation of ribosomal RNA, but permits the synthesis of other RNA species, including 45 S preribosomal RNA. In this work, the dose vs. response analysis of rRNA processing upon toyocamycin treatment of L5178Y cells is studied. It is shown that the latter steps of rRNA processing are more affected than the earlier. The mechanism responsible for the lack of conversion of toyocamycin-containing 45 S RNA into mature rRNA has not yet been elucidated. In order to investigate whether protein factors are involved in this mechanism, the effects of toyocamycin on the ability of preribosomal RNA to bind proteins and on the assembly of nucleolar preribosomes are investigated. The analogue allows the formation and the accumulation, in the nucleolus, of ribonucleoprotein complexes which contain 45 S RNA and newly synthesized proteins, but cannot be converted to mature ribosomal subunits. These complexes are not clearly distinguishable from 80 S particles synthesized in the absence of toyocamycin, with respect to their sedimentation rate in linear sucrose gradients, to their protein/RNA ratio and to their density measured in metrizamide gradients.
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002460:Cell Line; D002466:Cell Nucleolus / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D009698:Nucleoproteins / Q000096:biosynthesis*; D012335:RNA, Ribosomal / Q000096:biosynthesis*; D012261:Ribonucleoproteins / Q000096:biosynthesis*; D012270:Ribosomes / Q000187:drug effects / Q000502:physiology*; D014127:Toyocamycin / Q000494:pharmacology*
D000903:Antibiotics, Antineoplastic; D009698:Nucleoproteins; D012335:RNA, Ribosomal; D012261:Ribonucleoproteins; D014127:Toyocamycin